BURLINGTON, Mass., Jan. 3, 2024
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that
Company management will present at the 42nd Annual J.P. Morgan
Healthcare Conference in San Francisco,
CA, on Thursday, January 11,
2024, at 7:30 am PST. The live
webcast can be accessed through the Azenta investor relations
website at https://investors.azenta.com/events. A replay of the
webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA)
is a leading provider of life sciences solutions worldwide,
enabling impactful breakthroughs and therapies to market faster.
Azenta provides a full suite of reliable cold-chain sample
management solutions and multiomics services across areas such as
drug development, clinical research and advanced cell therapies for
the industry's top pharmaceutical, biotech, academic and healthcare
institutions globally. Our global team delivers and supports these
products and services through our industry-leading brands,
including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro,
Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations
in North America, Europe and Asia. For more
information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-42nd-annual-jp-morgan-healthcare-conference-302025682.html
SOURCE Azenta